JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TACO
4226
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $144K | ﹤0.01% |
42,001
+32,539
| +344% | +$208K |
2017 Q4
9 quarters
|
|
4227
Barings BDC
BBDC
$904M
| $142K | ﹤0.01% |
19,000
-51,002
| -73% | -$484K |
2015 Q4
17 quarters
|
|
4228
PUT
Thermo Fisher Scientific
TMO
$247B
| $142K | ﹤0.01% |
500
-26,400
| -98% | -$8.32M |
2018 Q2
7 quarters
|
|
4229
Viridian Therapeutics
VRDN
$2.16B
| $142K | ﹤0.01% |
21,290
| – | – |
2017 Q3
10 quarters
|
|
|
TGH
4230
DELISTED
Textainer Group Holdings limited
TGH
| $142K | ﹤0.01% |
17,296
-4,118
| -19% | -$37.6K |
2016 Q4
13 quarters
|
|
4231
Coastal Financial
CCB
$624M
| $141K | ﹤0.01% |
13,416
-5,189
| -28% | -$81.1K |
2018 Q3
6 quarters
|
|
|
SACH
4232
Sachem Capital Corp
SACH
$43.9M
| $141K | ﹤0.01% |
81,278
+19,507
| +32% | +$72K |
2019 Q2
3 quarters
|
|
4233
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.73B
| $140K | ﹤0.01% |
4,250
| – | – |
2017 Q2
11 quarters
|
|
|
JPUS
4234
JPMorgan Diversified Return US Equity ETF
JPUS
$454M
| $140K | ﹤0.01% |
2,379
-10
| -0.4% | -$733 |
2015 Q4
17 quarters
|
|
|
NVEE
4235
DELISTED
NV5 Global
NVEE
| $140K | ﹤0.01% |
13,640
+188
| +1% | +$2.51K |
2017 Q3
10 quarters
|
|
4236
ProShares UltraShort S&P500
SDS
$361M
| $138K | ﹤0.01% |
+181
| New | +$123K |
2020 Q1
0 quarters
|
|
4237
UNIFI
UFI
$122M
| $138K | ﹤0.01% |
11,951
-4,123
| -26% | -$84.6K |
2013 Q2
27 quarters
|
|
4238
CALL
AB InBev
BUD
$146B
| $137K | ﹤0.01% |
3,100
-27,600
| -90% | -$1.8M |
2019 Q3
2 quarters
|
|
4239
Kiniksa Pharmaceuticals
KNSA
$5.95B
| $137K | ﹤0.01% |
8,895
+4,314
| +94% | +$67.5K |
2018 Q3
6 quarters
|
|
4240
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.88B
| $137K | ﹤0.01% |
3,197
+270
| +9% | +$14.2K |
2016 Q1
16 quarters
|
|
4241
PAR Technology
PAR
$613M
| $137K | ﹤0.01% |
10,623
-20,214
| -66% | -$529K |
2018 Q2
7 quarters
|
|
4242
Simulations Plus
SLP
$374M
| $137K | ﹤0.01% |
3,920
+3
| +0.1% | +$100 |
2017 Q4
9 quarters
|
|
|
SBE.WS
4243
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
| – | – |
0
| – | – |
2020 Q1
0 quarters
|
|
4244
Amneal Pharmaceuticals
AMRX
$7.15B
| $136K | ﹤0.01% |
38,979
-3,359
| -8% | -$14.2K |
2018 Q2
7 quarters
|
|
4245
Invesco Zacks Mid-Cap ETF
CZA
$171M
| $136K | ﹤0.01% |
2,575
+85
| +3% | +$5.95K |
2016 Q4
13 quarters
|
|
4246
iShares Core MSCI International Developed Markets ETF
IDEV
$32.2B
| $135K | ﹤0.01% |
+3,042
| New | +$162K |
2020 Q1
0 quarters
|
|
4247
Luxfer Holdings
LXFR
$466M
| $135K | ﹤0.01% |
9,580
-27,795
| -74% | -$442K |
2016 Q1
16 quarters
|
|
4248
Valhi
VHI
$422M
| $135K | ﹤0.01% |
10,911
-7,486
| -41% | -$130K |
2016 Q4
13 quarters
|
|
|
FFNW
4249
DELISTED
First Financial Northwest, Inc
FFNW
| $135K | ﹤0.01% |
13,494
+3,153
| +30% | +$42.6K |
2016 Q4
13 quarters
|
|
|
PACD
4250
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $135K | ﹤0.01% |
314,873
-64,928
| -17% | -$122K |
2018 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.